DDDCX
Price
$20.05
Change
-$0.02 (-0.10%)
Updated
Sep 20 closing price
VEMPX
Price
$340.02
Change
-$2.46 (-0.72%)
Updated
Sep 20 closing price
Ad is loading...

DDDCX vs VEMPX

Header iconDDDCX vs VEMPX Comparison
Open Charts DDDCX vs VEMPXBanner chart's image
13D Activist C
Price$20.05
Change-$0.02 (-0.10%)
VolumeN/A
CapitalizationN/A
Vanguard Extended Market Index InstlPlus
Price$340.02
Change-$2.46 (-0.72%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DDDCX vs VEMPX Comparison Chart
Loading...
VS
DDDCX vs. VEMPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDDCX is a Buy and VEMPX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VEMPX has more cash in the bank: 107B vs. DDDCX (141M). VEMPX pays higher dividends than DDDCX: VEMPX (1.22) vs DDDCX (0.00). DDDCX was incepted earlier than VEMPX: DDDCX (12 years) vs VEMPX (14 years). DDDCX is a more actively managed with annual turnover of: 91.00 vs. VEMPX (11.00). DDDCX has a lower initial minimum investment than VEMPX: DDDCX (2500) vs VEMPX (100000000). VEMPX annual gain was more profitable for investors over the last year : 27.58 vs. DDDCX (9.44). VEMPX return over 5 years is better than : 55.74 vs. DDDCX (0.72).
DDDCXVEMPXDDDCX / VEMPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years14 years-
Gain YTD0.45110.6874%
Front LoadN/AN/A-
Min. Initial Investment25001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets141M107B0%
Annual Yield % from dividends0.001.22-
Returns for 1 year9.4427.5834%
Returns for 3 years-25.02-0.663,814%
Returns for 5 years0.7255.741%
Returns for 10 years18.54125.7015%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX1.190.02
+1.71%
CytomX Therapeutics
KBR63.580.02
+0.03%
KBR
UCTT34.50-0.37
-1.06%
Ultra Clean Holdings
SRI12.11-0.34
-2.73%
Stoneridge
CYCC0.99-0.03
-2.82%
Cyclacel Pharmaceuticals